文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

开发并验证一种新的列线图预测根治性肾输尿管切除术术后膀胱内复发:一项多中心研究。

Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study.

机构信息

Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, No. 9 Dongdan Santiao, Dongcheng District, Beijing, 100730, China.

Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Nanli, Panjiayuan, Chaoyang District, Beijing, 100021, China.

出版信息

J Cancer Res Clin Oncol. 2023 Oct;149(13):11223-11231. doi: 10.1007/s00432-023-05016-2. Epub 2023 Jun 24.


DOI:10.1007/s00432-023-05016-2
PMID:37355502
Abstract

OBJECTIVE: This study aimed to establish and validate nomograms to predict the probability of intravesical recurrence (IVR) after radical nephroureterectomy (RNU) for upper urinary tract epithelial carcinoma (UTUC). METHODS: Clinical data of 528 patients with UTUC after RNU were collected from two medical centers between 2009 and 2020. We used the least absolute shrinkage and selection operator (LASSO) regression to select variables for multivariable Cox regression analysis in the training cohort and included independent risk factors into nomogram models predicting IVR-free survival (IVRFS). Another center was applied as the external cohort to validate the predictive accuracy and discriminative ability of the nomogram by performing area under the receiver operating curve (AUC), consistency index (C-index), and calibration curve. RESULTS: History of bladder cancer, tumor size, preoperative urine cytology, postoperative instillation, Ki-67, and platelet-to-lymphocyte ratio (PLR) were identified as independent risk factors for IVR. The prognosis model including these predictors demonstrated excellent discriminatory performance in both the training cohort (C-index, 0.814) and external validation cohort (C-index, 0.748). The calibration plots of the nomogram revealed good consistency in both cohorts. Finally, patients could be classified into two risk groups based on scores obtained from the nomogram, with significant differences in IVRFS. CONCLUSION: Our study provided a reliable nomogram for predicting the probability of IVR in patients with UTUC after RNU. Risk stratification based on this model may assist urologists make optimal clinical decisions on the management of UTUC.

摘要

目的:本研究旨在建立和验证列线图,以预测上尿路上皮癌(UTUC)患者行根治性肾输尿管切除术(RNU)后膀胱内复发(IVR)的概率。

方法:收集了 2009 年至 2020 年两个医疗中心 528 例接受 RNU 治疗的 UTUC 患者的临床资料。我们使用最小绝对收缩和选择算子(LASSO)回归在训练队列中选择多变量 Cox 回归分析的变量,并将独立的危险因素纳入预测 IVR 无复发生存(IVRFS)的列线图模型中。另一个中心被用作外部队列,通过绘制受试者工作特征曲线(AUC)下面积、一致性指数(C-index)和校准曲线来验证列线图的预测准确性和判别能力。

结果:膀胱癌病史、肿瘤大小、术前尿液细胞学检查、术后灌注、Ki-67 和血小板与淋巴细胞比值(PLR)被确定为 IVR 的独立危险因素。包括这些预测因子的预后模型在训练队列(C 指数为 0.814)和外部验证队列(C 指数为 0.748)中均具有出色的判别性能。列线图的校准图显示两个队列均具有良好的一致性。最后,根据列线图获得的评分,患者可分为两个风险组,两组之间 IVRFS 差异有统计学意义。

结论:本研究为预测 RNU 治疗后 UTUC 患者 IVR 概率提供了一种可靠的列线图。基于该模型的风险分层可能有助于泌尿科医生在 UTUC 的管理方面做出最佳的临床决策。

相似文献

[1]
Development and external validation of a novel nomogram to predict intravesical recurrence after radical nephroureterectomy: a multicenter study.

J Cancer Res Clin Oncol. 2023-10

[2]
A novel nomogram for predicting extraurothelial recurrence in patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.

J Cancer Res Clin Oncol. 2023-11

[3]
Development and validation of a nomogram based on geriatric nutritional risk index for predicting prognosis and postoperative complications in surgical patients with upper urinary tract urothelial carcinoma.

J Cancer Res Clin Oncol. 2023-12

[4]
Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.

J Cancer Res Clin Oncol. 2023-9

[5]
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.

Eur Urol. 2014-12-6

[6]
Creatinine-Cystatin C Ratio as a Promising Prognostic Biomarker in Patients With UTUC After Radical Nephroureterectomy.

Clin Genitourin Cancer. 2025-8

[7]
External validation of current quality care metrics after radical nephroureterectomy.

BJU Int. 2025-8

[8]
The long-term outcome of nephron-sparing surgery versus radical nephroureterectomy for organ-localized upper urinary tract urothelial carcinoma: a population-based study of 1969 patients.

J Cancer Res Clin Oncol. 2023-11

[9]
Radiomics Nomogram Based on Optimal Volume of Interest Derived from High-Resolution CT for Preoperative Prediction of IASLC Grading in Clinical IA Lung Adenocarcinomas: A Multi-Center, Large-Population Study.

Technol Cancer Res Treat. 2024

[10]
Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.

Eur Urol. 2016-7-28

引用本文的文献

[1]
Predictive Value of the Platelet-Lymphocyte Ratio for Intravesical Recurrence After Radical Nephroureterectomy: A Retrospective Study.

J Inflamm Res. 2024-12-11

本文引用的文献

[1]
Ureteroscopy and tailored treatment of upper tract urothelial cancer: recent advances and unmet needs.

BJU Int. 2022-7

[2]
Cancer statistics, 2022.

CA Cancer J Clin. 2022-1

[3]
Comparison of the Prognostic Value of Ki-67 and Programmed Cell Death Ligand-1 in Patients with Upper Tract Urothelial Carcinoma.

J Clin Med. 2021-8-21

[4]
Developing a nomogram for predicting intravesical recurrence after radical nephroureterectomy: a retrospective cohort study of mainland Chinese patients.

Jpn J Clin Oncol. 2021-7-1

[5]
Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.

World J Surg Oncol. 2020-10-23

[6]
Macroscopic somatic clonal expansion in morphologically normal human urothelium.

Science. 2020-10-2

[7]
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.

Eur Urol. 2021-1

[8]
Risk factors and oncological outcome for intravesical recurrence in organ-confined upper urinary tract urothelial carcinoma patients after radical nephroureterectomy: A propensity score-matched case control study.

Int J Surg. 2020-2-17

[9]
STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery.

Int J Surg. 2019-11-6

[10]
Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication?

Transl Androl Urol. 2019-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索